Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects.
Adler SP, Lewis N, Conlon A, Christiansen MP, Al-Ibrahim M, Rupp R, Fu TM, Bautista O, Tang H, Wang D, Fisher A, Culp T, Das R, Beck K, Tamms G, Musey L; V160-001 Study Group. Adler SP, et al. Among authors: beck k. J Infect Dis. 2019 Jul 2;220(3):411-419. doi: 10.1093/infdis/jiz141. J Infect Dis. 2019. PMID: 31535143 Clinical Trial.
A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
Liu Y, Freed DC, Li L, Tang A, Li F, Murray EM, Adler SP, McVoy MA, Rupp RE, Barrett D, Ye X, Zhang N, Beck K, Culp T, Das R, Song L, Vora K, Zhu H, Wang D, Espeseth AS, An Z, Musey L, Fu TM. Liu Y, et al. Among authors: beck k. J Virol. 2019 Nov 13;93(23):e00747-19. doi: 10.1128/JVI.00747-19. Print 2019 Dec 1. J Virol. 2019. PMID: 31511385 Free PMC article. Clinical Trial.
Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial.
Das R, Blázquez-Gamero D, Bernstein DI, Gantt S, Bautista O, Beck K, Conlon A, Rosenbloom DIS, Wang D, Ritter M, Arnold B, Annunziato P, Russell KL; V160-002 study group. Das R, et al. Among authors: beck k. Lancet Infect Dis. 2023 Dec;23(12):1383-1394. doi: 10.1016/S1473-3099(23)00343-2. Epub 2023 Aug 31. Lancet Infect Dis. 2023. PMID: 37660711 Clinical Trial.
Survive and Thrive: Outcomes of Children Enrolled in a Follow-Up Clinic for Small and Sick Newborns in Rural Rwanda.
Nshimyiryo A, Barnhart DA, Nemerimana M, Beck K, Wilson K, Mutaganzwa C, Bigirumwami O, Shema E, Uwamahoro A, Itangishaka C, Havugarurema S, Sayinzoga F, Baganizi E, Magge H, Kirk CM. Nshimyiryo A, et al. Among authors: beck k. Healthcare (Basel). 2024 Nov 26;12(23):2368. doi: 10.3390/healthcare12232368. Healthcare (Basel). 2024. PMID: 39684993 Free PMC article.
Choice and motor impulsivity in Veterans with mild traumatic brain injury with and without history of suicide attempt.
Interian A, Myers CE, Brenner LA, Sweeney R, Osterberg T, Reddy V, Barnhart M, Hill LS, Miller RB, Beck KD, Cominski TP, Chan CC, Shafritz KM, Goodman MS, Hazlett EA. Interian A, et al. Among authors: beck kd. Psychiatry Res. 2024 Dec;342:116265. doi: 10.1016/j.psychres.2024.116265. Epub 2024 Nov 20. Psychiatry Res. 2024. PMID: 39591742
Prehabilitative/rehabilitative exercise, nutrition, and psychological support for bladder cancer: A scoping review of randomized clinical trials.
Briggs LG, Parke SC, Beck KL, Sinha D, Gill V, Van Ligten MJ, Bain PA, Tyson MD 2nd, Abdul-Muhsin HM, Quillen JK, Dodoo CA, De Luigi AJ, Branstiter NL, Trinh QD, Psutka SP. Briggs LG, et al. Among authors: beck kl. Cancer. 2025 Jan 1;131(1):e35608. doi: 10.1002/cncr.35608. Epub 2024 Nov 2. Cancer. 2025. PMID: 39488730 Review.
1,358 results